A new drug showed promise in treating preeclampsia, a dangerous pregnancy complication, while the Trump administration's science policies and international conflicts continue to evolve, according to multiple news sources. Abigail Hendricks, a 33-year-old living in Cape Town, South Africa, benefited from a new drug trial for preeclampsia, a condition that posed a grave health risk during her fifth pregnancy, as reported by NPR News.
Hendricks, who was pregnant in the fall of 2024, described her excitement, stating, "For me, a baby is a blessing." The new drug offered hope in managing the condition. Meanwhile, the Trump administration's scientific agenda was being shaped by a diverse coalition, not solely by anti-science ideologues, according to Vox.
Simultaneously, the administration's foreign policy continued to be active. The US military campaign in Somalia was extensive, with more than 100 bombings last year, as reported by Vox. This campaign was a significant aspect of President Donald Trump's second term.
In other news, a type of personalized cell therapy, CAR-T therapy, appeared to reset the immune system and alleviate severe symptoms in eight children and adolescents with autoimmune disorders, according to Nature News. Additionally, this week's headlines, drawing from multiple news sources, included the controversial departure of US Deputy Health Secretary Jim O'Neill, calls for collaboration in Bangladesh, and calls for regime change in Iran, as reported by Vox. Other key stories included the Justice Department's lawsuit against Harvard and the intensified search for missing Nancy Guthrie, and the likely poisoning of Alexei Navalny.
Discussion
AI Experts & Community
Be the first to comment